How to launch a wearable comes down to a short sequence. Pick one job the device does better than the watch or ring your buyer already owns, write every claim so it stays inside the FDA's general wellness policy (or budget for clearance if it cannot), and solve sizing and battery before you spend on ads. Then prove demand with deposits or pre-orders, put finished units on reviewers' bodies weeks before launch, and sell direct before you chase retail.
Blazon has watched that sequence play out across 500+ product launches, including the Kuura smart ring, which went up against Oura with a fraction of Oura's budget. The wearables that struggle rarely struggle on sensors. They struggle on the claim, the fit or the charger.
A wearable is judged every night, not on launch day
A wearable is worn through sleep, showers and workouts, and the buyer makes up their mind on day ten, not day one.
The sensor is the price of entry. What earns the review and the renewal is whether the thing is comfortable at 3 a.m., whether it lasts the weekend, and whether the app tells the buyer something new.
Wearable tech is also a category where your marketing copy can turn your product into a medical device. That decision sits right behind positioning.
Position against Apple, Oura and Whoop by owning a job they do not
You will not beat the incumbents on a spec sheet. Apple Watch Series 11 starts at $399, runs up to 24 hours on a charge and carries FDA-cleared hypertension notifications. Oura announced six million paid members in October 2026, and Whoop sells a membership with the device included.
What a new brand can own is a narrower job: one person, one place on the body, one problem. A ring for sleep that nobody notices. A band built for one sport, or a clip that remembers your conversations.
The narrower the job, the easier the ad, the press angle and the review headline. "Better health tracking" is Apple's sentence, and Apple can say it louder than you.
Kuura is Blazon's own example: a minimalist health-tracking ring from Finland, launched into a category dominated by Oura. Blazon ran paid ads in English, German and the Nordic languages and took the story to wearable press, and the ring raised more than €800K on Indiegogo from 5,000+ backers in 30+ countries.
Positioning against an incumbent is also a legal question here. In October 2025, the US International Trade Commission's orders in Oura's patent case took effect, which Oura says effectively banned the import and sale of Ultrahuman smart rings in the US, while RingConn settled with a multi-year license and royalty payments to Oura. If you are building a ring, the freedom-to-operate review belongs in the same month as the industrial design review.
The health-claim line: FDA general wellness policy vs a regulated device
For a wearable, the FDA cares less about the sensor than about the sentence printed next to it. The same optical reading can be a wellness feature or a regulated medical device, depending on the claim.
The rule book is the FDA's General Wellness: Policy for Low Risk Devices, in the version dated January 6, 2026. Sleep, fitness and stress claims that never name a disease sit inside it, and so do claims that a tracked habit may lower the risk of a chronic condition such as high blood pressure.
The 2026 text names the sensors wearable founders actually use. Blood pressure, oxygen saturation, glucose and heart rate variability estimates from non-invasive sensors can stay in the wellness lane if the outputs are for wellness only and clinical-looking values are validated. Name a disease or a diagnostic threshold, send alerts that call for clinical action or promise "medical grade" accuracy, and the product is out, whether that line sits on the box, in an ad or on an app screen.
Whoop found the edge in public. In July 2025 an FDA warning letter told the company its Blood Pressure Insights feature was being marketed without clearance, and less than six months later the 2026 guidance listed a wrist-worn optical blood pressure wearable as a wellness example, provided the values are validated.
The big brands split the difference: the everyday product stays in wellness, and any feature that names a condition goes through the FDA, as Apple's hypertension notifications did on September 11, 2025 and Whoop's ECG feature on April 4, 2025. If the job itself is medical, clearance is the product, and Blazon's guide to launching a medical device covers the pathways, what you can say before and after clearance, and the evidence the FTC expects.
| What you want to say | Where it sits | Why |
|---|---|---|
| "Tracks your sleep trends and recovery" | General wellness | Sleep management is a listed wellness use |
| "Shows blood pressure trends for recovery" | General wellness, if the values are validated | Matches the 2026 guidance's wrist-worn example |
| "Medical-grade accuracy" or "replaces your cuff" | Outside wellness | Clinical-grade and substitution claims are listed exclusions |
| "Alerts you to possible hypertension" | Regulated device | Names a condition, and Apple cleared it through a 510(k) |
| "Measures glucose through microneedles" | Not low risk | The guidance treats skin-penetrating sensors as invasive |
Write the claim sheet before the website, give it to your ad team, PR team and app designers, and have regulatory counsel sign it off. Blazon's health and wellness launches start with a claims audit for exactly this reason.
The FTC reads your marketing, including your press release
The FDA decides what your product is. The Federal Trade Commission decides whether what you say about it is true, and its Health Products Compliance Guidance counts packaging, influencer posts, press releases, press interviews and trade show demos as advertising. A creator who says your ring "caught my heart problem" is making a claim you have to substantiate, and adding "may" or "helps" does not soften it, because the FTC judges the net impression of the whole ad.
Then there is the data. Under changes the FTC finalized in April 2024, its Health Breach Notification Rule reaches the health apps and similar technologies that HIPAA does not, and Washington's My Health My Data Act bars collecting or sharing consumer health data without consent.
For AI wearables, privacy is the pitch. Bee, a $74.99 wearable that summarizes your conversations, leads with it: its site says audio is processed instantly and then deleted, and that not even Amazon can access a user's data unless they choose to share it. A device that listens all day has to answer the privacy question before the buyer asks.
Sizing and fit are a logistics problem
A watch strap adjusts. A ring does not, and that one fact reshapes your checkout, your inventory and your launch calendar.
Samsung tells buyers that because of the sensors inside the Galaxy Ring, their usual ring size may not be the best fit. It sells sizes 5 through 15, ships a sizing kit first and asks buyers to wear the sample for more than 24 hours, including while sleeping.
Oura runs the same flow with a "Size Later" option and a complimentary kit, and the ring does not ship until the buyer confirms the size.
That means two deliveries per order, a size curve to forecast before production, and a gap of days between payment and size confirmation where buyers can go cold. Make the kit feel premium, send a short email sequence while it sits on the buyer's finger, and read a confirmed size as the strongest buying signal you will get.
Bands and glasses have their own version. Meta launched Meta Ray-Ban Display and its EMG wristband at $799 through select US retailers with demos, in its own words "to make sure customers get the glasses and band that's perfect for them."
Battery and comfort decide the review
Battery life is the spec every wearable review tests, because the reviewer lives with it. The bar is public: Apple Watch Series 11 at up to 24 hours, Samsung Galaxy Ring at up to 7 days, Oura Ring 4 at 5 to 8 days and Whoop at 14+ days.
Read Oura's wording closely. It says the Oura Ring 4 battery lasts between 5 and 8 days depending on ring size and lifestyle. If your battery life varies by size, your claim has to hold for the smallest one you sell.
Publish the worst case. A reviewer wearing your smallest size will find it either way.
Comfort is the other half of the same decision. A sleep tracker that comes off every night to charge stops being a sleep tracker, which is why Oura sells titanium, recessed sensors and 24/7 wear as hard as it sells accuracy.
App and subscription: decide what the hardware is for
Investors push wearable founders toward recurring revenue. Buyers push back on paying monthly for hardware they already own. The model you choose decides which argument you have on launch day.
There are four models in the US market. Apple sells hardware only. Oura sells hardware plus a membership at $5.99 a month or $69.99 a year, with the first month free and data export as a CSV file even without one.
Whoop's membership tiers each include a device and a charger, with Blood Pressure Insights, ECG and irregular rhythm notifications reserved for the top tier and a free trial on a certified pre-owned device. Bee sells cheap hardware, $74.99, and puts select features behind a Bee Pro subscription.
Blazon's rule: the box has to be worth buying without the subscription, and the subscription has to deliver something new every month. Cripple the free tier and the reviews say so. Charge for data the hardware already collected and churn arrives fast.
The app has to be approved and live in both app stores before the first unit lands, so put app review on the launch calendar next to freight.
AI wearables carry the hardest version of this problem. Humane's AI Pin, the best-known standalone AI device of the first wave, was switched off in February 2025, less than a year after it shipped. Blazon's take on why the second wave of AI hardware is different covers what that means for an AI wearable launching now.
Pre-orders and deposits: prove demand before the production run
Interest is free. Blazon's Deposit Test is blunt: if people will not put down a small refundable deposit, they will not pay full price on launch day.
For a wearable, deposits also tell you which sizes, finishes and markets to build first. The demand validation ladder covers the steps before money changes hands.
Two US rules shape how you take that money. A wearable with Bluetooth is a radio-frequency device, and under the FCC's 47 CFR 2.803 you can take conditional sales before authorization only with a prominent disclosure. It must say delivery depends on completing equipment authorization and what refund applies if it fails, and nothing can be delivered until it succeeds.
The FTC's Mail Order Rule is the second. You need a reasonable basis to ship within the time you state, or within 30 days if you state nothing, and if you slip you must offer buyers the choice to accept the delay or cancel for a prompt refund.
Wearable ship dates tend to slip on firmware and certification, not only at the factory, so pick a window you can defend. The deposit and ship-date mechanics are in Blazon's Shopify pre-orders playbook for hardware founders.
Then keep the list warm. Blazon calls the months between deposit and delivery the Dead Zone, and size confirmation, app beta invitations and early wear-test data give buyers a reason to stay through it.
Health buyers do pre-order when the story is right. Pillo Health, later acquired by Stanley Black & Decker, is a home-health robot rather than a wearable, but it sold to the same buyer: 15K+ units pre-ordered on the way to $2.5M in sales.
Reviewers and press: put the device on wrists weeks early
A wearable review is a test of lived use. Reviewers wear the device to bed, through workouts and across several charge cycles, so seed finished units weeks before the embargo lifts.
Send the sizing kit before the device. A reviewer wearing the wrong size gets worse readings and a worse fit, and writes about both.
Pitch the press your buyer reads. For Kuura that meant outreach to Wareable, TechRadar and The Verge, and 15 media features including all three.
Health products need a story that sounds human before it sounds clinical. Pillo's launch story was built on the three things a new category has to explain fast (what it is, where it fits in the day and why anyone should care), and it earned 120+ press features.
Your press kit is advertising in the FTC's eyes, so every health line in it comes off the claim sheet. The embargo lift, the paid campaign and the pre-order email should land the same morning, which is the Launch Moment Blazon's launch PR and paid media teams plan as one date.
Retail vs DTC: sell direct first, earn the shelf
Direct-to-consumer comes first for almost every new wearable. You control the sizing flow, the subscription offer at checkout, the claim language on the page and the customer data that plans the second production run.
Retail earns its margin once a demo sells the product faster than a product page does. Meta launched its display glasses through a limited set of US stores offering demos, and Oura's authorized retailers sell sizing kits separately with a credit toward the ring.
US health buyers also spend HSA and FSA dollars. Oura lists its membership as HSA/FSA eligible, so check your own product's eligibility with advisers before it reaches an ad.
A DTC launch lives or dies on the store. Blazon builds the Shopify store and pre-order flow alongside the campaign, so the page, the sizing step and the deposit work from the first click.
How Blazon launches wearables
Blazon runs a wearable launch as one product launch plan: positioning and the claim sheet first, then pre-orders, press and paid media against the same story. That work runs through its hardware launch agency for consumer tech and IoT and its health and wellness launch team.
On Kineon's MOVE+ 2.0, Blazon shaped the relaunch so the second-generation wearable stood on its own with a refreshed brand, with ads, campaign pages and a launch film planned as one campaign. On HelloEar by Xiaomi, the job was turning custom-fit technology into one clear benefit, earphones made for your ears, and the product reached $1.2M in revenue at launch.
The wearables that win are rarely the ones with the most sensors. They are the ones people forget they are wearing.
Frequently asked questions
How do you launch a wearable device?
Pick one job the device does better than what the buyer already wears, and keep every claim inside the FDA's general wellness policy unless you plan to seek clearance. Then solve sizing and battery, validate demand with deposits, seed reviewers weeks early and sell direct before retail.
Does a wearable need FDA approval?
Not if it is a low-risk product whose claims stay within the FDA's general wellness policy, such as fitness, stress or sleep tracking. It becomes a regulated medical device, usually needing FDA clearance or authorization, if it is intended to diagnose, monitor or treat a disease, such as hypertension or sleep apnea notifications. The FDA reads intended use from your labeling, ads, app interface and functionality, so your marketing can change the answer.
What is wearable technology and how does it work?
Wearable technology is electronics worn on the body: smartwatches, smart rings, fitness bands, smart glasses and clip-on AI devices. Most collect data through optical sensors, accelerometers and temperature sensors, then send it over Bluetooth to a phone app that turns it into scores and trends.
What are the biggest companies in wearable tech?
In the US, a new wearable gets compared with Apple and Samsung in watches and rings, Google's Fitbit and Garmin in fitness, Oura in smart rings, Whoop in subscription bands and Meta in AI glasses. A new brand wins by beating them for one buyer on one job.
Can you take pre-orders before FCC certification?
Yes, in the US, under the FCC's limited marketing rule in 47 CFR 2.803. Buyers must see a prominent disclosure that delivery depends on completing equipment authorization, plus what refund applies if it fails. Nothing can be delivered until authorization is complete.
Should a smart ring have a subscription?
Only if the subscription delivers something new over time and the ring is still worth owning without it. Oura charges $5.99 a month on top of the ring, Whoop folds the device into a membership, and Bee keeps the hardware cheap with optional paid features.
Why are smart rings and bands gaining on smartwatches?
Smart rings and screenless bands sell on what a daily-charge watch struggles to offer: multi-day battery and something comfortable enough to sleep in. Apple Watch Series 11 is rated at up to 24 hours, against 5 to 8 days for Oura Ring 4 and 14+ days for Whoop.
